ES2187984T3 - Sintesis de derivados de acridina que son inhibidores resistentes a multiples farmacos. - Google Patents
Sintesis de derivados de acridina que son inhibidores resistentes a multiples farmacos.Info
- Publication number
- ES2187984T3 ES2187984T3 ES98934892T ES98934892T ES2187984T3 ES 2187984 T3 ES2187984 T3 ES 2187984T3 ES 98934892 T ES98934892 T ES 98934892T ES 98934892 T ES98934892 T ES 98934892T ES 2187984 T3 ES2187984 T3 ES 2187984T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- synthesis
- compound
- multiple drugs
- acridine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 title 1
- 229940027998 antiseptic and disinfectant acridine derivative Drugs 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 150000003840 hydrochlorides Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000012026 peptide coupling reagents Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un método para la síntesis de un compuesto de fórmula (IV) **(Fórmula)** que comprende los pasos de: (i) hacer reaccionar un compuesto de fórmula (II): **(Fórmula)** con un compuesto de fórmula (III): **(Fórmula)** en presencia de un reactivo de copulación de péptidos basado en tetrametiluronio y una base amínica para dar una base libre de fórmula (IV); (ii) convertir opcionalmente el compuesto de fórmula (IV) en la sal de HCl de fórmula (I): **(Fórmula)**
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9710612.4A GB9710612D0 (en) | 1997-05-23 | 1997-05-23 | Synthesis of acridine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2187984T3 true ES2187984T3 (es) | 2003-06-16 |
Family
ID=10812906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98934892T Expired - Lifetime ES2187984T3 (es) | 1997-05-23 | 1998-05-22 | Sintesis de derivados de acridina que son inhibidores resistentes a multiples farmacos. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6248891B1 (es) |
| EP (1) | EP0983246B1 (es) |
| JP (1) | JP4390861B2 (es) |
| KR (1) | KR100536155B1 (es) |
| CN (1) | CN1178918C (es) |
| AT (1) | ATE228506T1 (es) |
| AU (1) | AU744402B2 (es) |
| BR (1) | BR9809143A (es) |
| CA (1) | CA2289492C (es) |
| DE (1) | DE69809733T2 (es) |
| DK (1) | DK0983246T3 (es) |
| ES (1) | ES2187984T3 (es) |
| GB (1) | GB9710612D0 (es) |
| HK (1) | HK1023995A1 (es) |
| HU (1) | HUP0002083A3 (es) |
| IL (1) | IL132593A (es) |
| PL (1) | PL190109B1 (es) |
| PT (1) | PT983246E (es) |
| WO (1) | WO1998052923A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| MA26696A1 (fr) | 1998-10-08 | 2004-12-20 | Smithkline Beecham Plc | Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |
| DK1189637T3 (da) * | 1999-05-17 | 2006-12-11 | Cancer Res Ventures Ltd | Produkter til forbedring af biotilgængeligheden for oralt indgivne medikamenter |
| SI21507A (sl) | 2003-05-16 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo spojin z ace inhibitornim delovanjem |
| US7829578B1 (en) | 2005-12-12 | 2010-11-09 | Oregon Health & Science University | Aromatic ketones and uses thereof |
| WO2008064011A1 (en) | 2006-11-13 | 2008-05-29 | The Government Of The U.S. Of America As Represented By The Department Of Veterans Affairs | Acridone compounds |
| US8598354B2 (en) | 2008-12-05 | 2013-12-03 | University Of South Florida | Compounds having antiparasitic or anti-infectious activity |
| IL277335B2 (en) * | 2018-03-21 | 2024-03-01 | Izumi Tech Llc | Analogues of alcridar with deuterium |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2783680B2 (ja) * | 1991-01-11 | 1998-08-06 | ラボラトワール、グラクソ、ソシエテ、アノニム | アクリジン誘導体 |
| CZ104197A3 (en) * | 1994-10-05 | 1997-09-17 | Glaxo Wellcome Inc | Pharmaceutical preparation |
-
1997
- 1997-05-23 GB GBGB9710612.4A patent/GB9710612D0/en active Pending
-
1998
- 1998-05-22 PL PL98336937A patent/PL190109B1/pl not_active IP Right Cessation
- 1998-05-22 CA CA002289492A patent/CA2289492C/en not_active Expired - Fee Related
- 1998-05-22 KR KR10-1999-7010781A patent/KR100536155B1/ko not_active IP Right Cessation
- 1998-05-22 DE DE69809733T patent/DE69809733T2/de not_active Expired - Lifetime
- 1998-05-22 CN CNB988051265A patent/CN1178918C/zh not_active Expired - Fee Related
- 1998-05-22 WO PCT/EP1998/002991 patent/WO1998052923A1/en active IP Right Grant
- 1998-05-22 AT AT98934892T patent/ATE228506T1/de not_active IP Right Cessation
- 1998-05-22 IL IL13259398A patent/IL132593A/en not_active IP Right Cessation
- 1998-05-22 ES ES98934892T patent/ES2187984T3/es not_active Expired - Lifetime
- 1998-05-22 US US09/403,158 patent/US6248891B1/en not_active Expired - Fee Related
- 1998-05-22 EP EP98934892A patent/EP0983246B1/en not_active Expired - Lifetime
- 1998-05-22 BR BR9809143-3A patent/BR9809143A/pt not_active Application Discontinuation
- 1998-05-22 HU HU0002083A patent/HUP0002083A3/hu unknown
- 1998-05-22 JP JP54995998A patent/JP4390861B2/ja not_active Expired - Fee Related
- 1998-05-22 AU AU84344/98A patent/AU744402B2/en not_active Ceased
- 1998-05-22 PT PT98934892T patent/PT983246E/pt unknown
- 1998-05-22 DK DK98934892T patent/DK0983246T3/da active
-
2000
- 2000-05-25 HK HK00103130A patent/HK1023995A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0983246A1 (en) | 2000-03-08 |
| KR100536155B1 (ko) | 2005-12-14 |
| CA2289492C (en) | 2009-03-24 |
| JP2002502371A (ja) | 2002-01-22 |
| JP4390861B2 (ja) | 2009-12-24 |
| BR9809143A (pt) | 2000-08-01 |
| US6248891B1 (en) | 2001-06-19 |
| PT983246E (pt) | 2003-04-30 |
| AU744402B2 (en) | 2002-02-21 |
| KR20010012817A (ko) | 2001-02-26 |
| DE69809733D1 (de) | 2003-01-09 |
| HUP0002083A3 (en) | 2002-03-28 |
| HK1023995A1 (en) | 2000-09-29 |
| IL132593A (en) | 2004-07-25 |
| CN1255918A (zh) | 2000-06-07 |
| PL190109B1 (pl) | 2005-10-31 |
| IL132593A0 (en) | 2001-03-19 |
| HUP0002083A2 (hu) | 2001-04-28 |
| CN1178918C (zh) | 2004-12-08 |
| CA2289492A1 (en) | 1998-11-26 |
| GB9710612D0 (en) | 1997-07-16 |
| DE69809733T2 (de) | 2003-09-18 |
| EP0983246B1 (en) | 2002-11-27 |
| ATE228506T1 (de) | 2002-12-15 |
| PL336937A1 (en) | 2000-07-17 |
| WO1998052923A1 (en) | 1998-11-26 |
| DK0983246T3 (da) | 2003-03-24 |
| AU8434498A (en) | 1998-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2184408T3 (es) | Sistema transdermico que contiene un antioxidante. | |
| ES2187984T3 (es) | Sintesis de derivados de acridina que son inhibidores resistentes a multiples farmacos. | |
| HN1998000177A (es) | Compuestos azopoliciclicos condensados con arilo | |
| NO993814L (no) | Telemetrisystem for seismiske undersokelser | |
| GB0321295D0 (en) | Synthesis of protected pyrrolobenzodiazepines | |
| ECSP034831A (es) | Derivados sustituidos de la 2-piridina ciclohexano-1,4-diamina | |
| AR016481A1 (es) | Preparaciones farmaceuticas que se desintegran oralmente que contienen sildenafilo | |
| AR019507A1 (es) | Uso de los inhibidores de cyp2d6 en terapias de combinacion | |
| AU2003259100A8 (en) | System for assigning a funding source | |
| DE69603520D1 (de) | Leitfähiger Elektroneninjektor für lichtemittierende Dioden | |
| AR003937A1 (es) | Compuesto ciclico que tiene efecto antagonico al receptor de taquiquinina, proceso para producirlo y composicion farmaceutica que lo contiene. | |
| IT1319007B1 (it) | Sistema di gestione di una pluralita' di moduli vrm e relativo metododi sincronizzazione | |
| NO980050D0 (no) | Forbedret fremgangsmåte for havbunnsseismiske undersökelser | |
| ATE235462T1 (de) | Metalloproteinase-inhibitoren | |
| NO993277L (no) | Geofysisk undersökelsessystem med seismisk vibratorkilde som tilveiebringer et sammensatt sveip | |
| MY118828A (en) | Substituted amino compounds and their use as substances having an analgesic effect | |
| HUP9700654A2 (hu) | Teobromin tartalmú köhögéscsillapító készítmények | |
| IT1292437B1 (it) | Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti | |
| DK0991565T3 (da) | Seismiske opmålingsfartøjer | |
| ATE228760T1 (de) | Thrombininhibitoren | |
| DE60032600D1 (de) | Spermin:peptidhaltige tenside | |
| NO983540L (no) | Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering | |
| GB9927052D0 (en) | A marine seismic source | |
| AR032712A1 (es) | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen | |
| AU2002344845A8 (en) | Visual database for linking geography to seismic data |